These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy. Barr Fritcher EG; Voss JS; Jenkins SM; Lingineni RK; Clayton AC; Roberts LR; Halling KC; Talwalkar JA; Gores GJ; Kipp BR Cancer Cytopathol; 2013 Dec; 121(12):708-17. PubMed ID: 23839915 [TBL] [Abstract][Full Text] [Related]
25. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Njei B; McCarty TR; Varadarajulu S; Navaneethan U Gastrointest Endosc; 2017 Apr; 85(4):773-781.e10. PubMed ID: 27590963 [TBL] [Abstract][Full Text] [Related]
26. An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma. Kato A; Naitoh I; Miyabe K; Hayashi K; Yoshida M; Hori Y; Natsume M; Jinno N; Asano G; Kato H; Kuno T; Takahashi S; Kataoka H Dig Dis Sci; 2018 Dec; 63(12):3376-3381. PubMed ID: 30206756 [TBL] [Abstract][Full Text] [Related]
28. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806 [TBL] [Abstract][Full Text] [Related]
29. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma. Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363 [TBL] [Abstract][Full Text] [Related]
30. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay. Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902 [TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding. Kim DG; Park SY; You KR; Lee GB; Kim H; Moon WS; Chun YH; Park SH Genes Chromosomes Cancer; 2001 Jan; 30(1):48-56. PubMed ID: 11107175 [TBL] [Abstract][Full Text] [Related]
32. An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas. DeHaan RD; Kipp BR; Smyrk TC; Abraham SC; Roberts LR; Halling KC Hum Pathol; 2007 Mar; 38(3):491-9. PubMed ID: 17239935 [TBL] [Abstract][Full Text] [Related]
33. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310 [TBL] [Abstract][Full Text] [Related]
34. A multistep cytological approach for patients with jaundice and biliary strictures of indeterminate origin. Boldorini R; Paganotti A; Andorno S; Orlando S; Mercalli F; Orsello M; Ballarè M; Magnani C; Sartori M J Clin Pathol; 2015 Apr; 68(4):283-7. PubMed ID: 25681513 [TBL] [Abstract][Full Text] [Related]
35. Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients. Ainthachot S; Sa-Ngiamwibool P; Thanee M; Watcharadetwittaya S; Chamgramol Y; Pairojkul C; Deenonpoe R Hum Pathol; 2022 Aug; 126():31-44. PubMed ID: 35577140 [TBL] [Abstract][Full Text] [Related]
36. Genomic aberrations and survival in chronic lymphocytic leukemia. Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261 [TBL] [Abstract][Full Text] [Related]
37. Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization. Uhm KO; Park YN; Lee JY; Yoon DS; Park SH Cancer Genet Cytogenet; 2005 Feb; 157(1):37-41. PubMed ID: 15676145 [TBL] [Abstract][Full Text] [Related]
38. Fluorescence in situ hybridization for the detection of malignant bile duct strictures: has FISH found a new pond? Wamsteker EJ; Anderson MA Am J Gastroenterol; 2004 Sep; 99(9):1682-3. PubMed ID: 15330901 [TBL] [Abstract][Full Text] [Related]
39. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization. Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743 [TBL] [Abstract][Full Text] [Related]
40. Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma. Hamada S; Satoh K; Hirota M; Kanno A; Ishida K; Umino J; Ito H; Kikuta K; Kume K; Masamune A; Katayose Y; Unno M; Shimosegawa T Cancer Sci; 2011 Jan; 102(1):150-6. PubMed ID: 21029254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]